Optimizing Breathing and Blood Flow in Patients Treated With VA ECMO
ECMO-VP
Ventilation-Perfusion Matching and PEEP Titration in Patients Undergoing Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation (VA ECMO)
1 other identifier
interventional
10
1 country
2
Brief Summary
The aim of this study is to characterize ventilation/perfusion (V/Q) matching in adult patients receiving peripheral VA ECMO support while on mechanical ventilation, and to evaluate the impact of PEEP titration guided by Electrical Impedance Tomography (EIT) and esophageal pressure measurements on lung mechanics and V/Q optimization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2026
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 19, 2025
CompletedFirst Posted
Study publicly available on registry
August 26, 2025
CompletedStudy Start
First participant enrolled
January 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 28, 2027
February 2, 2026
October 1, 2025
11 months
August 19, 2025
January 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
V/Q match
Primary outcome measure: Reduction in shunt fraction (expressed in %) Secondary outcome measure: Reduction in dead space (expressed as volume) Respiratory mechanics will be recorded before and after best PEEP. Ventilation (L/min)/Perfusion (L/min) \[V/Q\] ratio comparing baseline with best PEEP (after PEEP optimization trial).
1 hour
Study Arms (1)
Lung physiology assessment
OTHERMeasurement of lung perfusion (via EIT) and transpulmonary pressure (via esophageal manometry) during decremental PEEP trial
Interventions
Measurement of lung perfusion (via EIT) and transpulmonary pressure (via esophageal manometry) during decremental PEEP trial
Eligibility Criteria
You may qualify if:
- Adults (≥18 years) undergoing mechanical ventilation during peripheral VA ECMO support for cardiogenic shock, cardiac arrest, or refractory heart failure.
- On ECMO support for at least 6 hours
- Swan-Ganz catheter required as standard clinical care
- Clinically stable in the estimation of the study investigator
You may not qualify if:
- Contraindications to EIT (e.g., presence of pacemaker or IMPELLA device for electrical interference)
- Patients without pulmonary flow (non-pulsatile pulmonary prSessure)
- Patients with known pulmonary embolism
- Imminent withdrawal of life support
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02115, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Anesthesia
Study Record Dates
First Submitted
August 19, 2025
First Posted
August 26, 2025
Study Start
January 27, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
February 28, 2027
Last Updated
February 2, 2026
Record last verified: 2025-10